Cargando…

Detection of HBV DNA in Cerumen and Sera of Hbsag Negative Patients with Chronic Hepatitis B Infection

Detalles Bibliográficos
Autores principales:	Gholami Parizad, E, Khosravi, A, Sayehmiri, K, Ranjbar, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2012
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372032/ https://www.ncbi.nlm.nih.gov/pubmed/22737579

Ejemplares similares

Comparing HBV Viral Load in Serum, Cerumen, and Saliva and Correlation With HBeAg Serum Status in Patients With Chronic Hepatitis B Infection
por: Gholami Parizad, Elaheh, et al.
Publicado: (2016)

Evaluation of Chronic Hepatitis B Infection in Patients with Seronegative HbsAg
por: Parizad, E Gholami, et al.
Publicado: (2012)

The Prevalence of Hearing Loss in Patients with Hepatitis B Infection Compared with Healthy Volunteers
por: Gholami Parizad, Elaheh, et al.
Publicado: (2017)

Prevalent HBeAg-negative HBV DNA-positive Chronic Hepatitis B Individuals in Bangladesh
por: Rashed Ul Islam, SM, et al.
Publicado: (2021)

HBV Genotyping in HBsAg-Positive Blood Donors from Southwestern Iran
por: Kohshour, Mojtaba Oraki, et al.
Publicado: (2010)

Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBV
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

Comparison of Immune Response in Mice Immunized with Recombinant PreS2/S-C18-27 Protein Derived from Hepatitis B Virus with Commercial Vaccine
por: Gholami Parizad, Elaheh, et al.
Publicado: (2022)

Nutritional Status and Anthropometric Indices in High School Girls in Ilam, West Iran
por: Jamalikandazi, Fatemeh, et al.
Publicado: (2016)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
por: Zeng, Zhan, et al.
Publicado: (2023)

Correlation Between HBsAg Quantitation and HBV DNA in HBeAg-Negative HBV/D Patients
por: Teriaky, Anouar, et al.
Publicado: (2013)

Correlation between HBsAg quantitative assay results and HBV DNA levels in chronic HBV
por: Ganji, Azita, et al.
Publicado: (2011)

Quantitative HBsAg versus HBV DNA in Predicting Significant Hepatitis Activity of HBeAg-Positive Chronic HBV Infection
por: Zhang, Zhanqing, et al.
Publicado: (2021)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
por: Gozlan, Yael, et al.
Publicado: (2022)

Response to Letter by Seibold regarding “Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes”
por: Oliver, Nick, et al.
Publicado: (2020)

Preventing the complications of forgotten tourniquet by using intelligent tourniquet: A letter to the editor
por: Parizad, Naser, et al.
Publicado: (2021)

HBV DNA and HBsAg: Early Prediction of Response to Peginterferon α-2a in HBeAg-Negative Chronic Hepatitis B
por: Zhang, Chong, et al.
Publicado: (2020)

Accumulation and Inspissation of Cerumen
por: Burnett, Swan M.
Publicado: (1875)

To Remove Impacted Cerumen
Publicado: (1901)

Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?
por: Chen, Tianyan, et al.
Publicado: (2013)

Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma
por: Pollicino, Teresa, et al.
Publicado: (2019)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
por: Liu, Xin, et al.
Publicado: (2023)

Shedding light on the “gray zone”: Hepatic fibrosis in chronic hepatitis B patients with fluctuating HBV DNA levels
por: Brown, Andrew, et al.
Publicado: (2022)

Detection of Antibodies Against DNA Polymerase of Hepatitis B Virus in HBsAg-Positive Sera Using ELISA
por: Rui, Li Xiang, et al.
Publicado: (1998)

Evaluation of Triple Fragment Vaccine HSPX (Rv2031c) + PPE44 (Rv2770c) + Mouse IgG(1 )(Fcγ2a) with Auxiliary Adjuncts IL-22 in Comparison with BCG Vaccine
por: Valizadeh, Azar, et al.
Publicado: (2022)

Inherited Thrombocytopenias: Combining High-Throughput Sequencing With Other Relevant Data
por: Ghosh, Kanjaksha, et al.
Publicado: (2019)

Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues
por: Tantiwetrueangdet, Anchalee, et al.
Publicado: (2018)

Evolution of full-length genomes of HBV quasispecies in sera of patients with a coexistence of HBsAg and anti-HBs antibodies
por: Zhou, Tai-Cheng, et al.
Publicado: (2017)

The Relationship Between Depression and Metabolic Syndrome: Systematic Review and Meta-Analysis Study
por: Ghanei Gheshlagh, Reza, et al.
Publicado: (2016)

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
por: Moini, Maryam, et al.
Publicado: (2022)

Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B
por: Song, Joon Chang, et al.
Publicado: (2011)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
por: Bazinet, Michel, et al.
Publicado: (2022)

A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition In Vitro
por: Salpini, Romina, et al.
Publicado: (2020)

Evaluating the Performance of PPE44, HSPX, ESAT-6 and CFP-10 Factors in Tuberculosis Subunit Vaccines
por: Valizadeh, Azar, et al.
Publicado: (2022)

Nucleic Acid Testing for the Detection of HBV DNA
por: Seto, Wai Kay, et al.
Publicado: (2011)

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas
por: Lan, Ting-Yuan, et al.
Publicado: (2023)

Comparison of Serum HBsAg Quantitation by Four Immunoassays, and Relationships of HBsAg Level with HBV Replication and HBV Genotypes
por: Tuaillon, Edouard, et al.
Publicado: (2012)

Hepatitis B virus (HBV) serological patterns among the HBsAg negative hospital attendees screened for immunization
por: Kafeero, Hussein Mukasa, et al.
Publicado: (2022)

Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection
por: Larsson, Simon B., et al.
Publicado: (2015)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
por: Salpini, Romina, et al.
Publicado: (2020)

Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA
por: Liu, Ya-Yun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lc8i5s49sdaf6i56ak0s1tqshd